Table 2.
Means for patient and control groups on the Strengths and Difficulties Questionnaire (SDQ); Autism Spectrum Screening Questionnaire (ASSQ); and Swanson, Nolan, and Pelham (SNAP) Questionnaire
| Group | Epilepsy CSE | Non‐epilepsy CSE | Controls | Population‐derived norms |
|---|---|---|---|---|
| Sex (female/male) | 20/24 | 19/20 | 9/7 | NA |
| Age at test | 13y 1moa | 10y 3moa | 12y 4moa | NA |
| SES (SD) | 33.6 (14.4) | 31.6 (16.1) | 26.9 (16.4) | NA |
| FSIQ (SD) | 72.2 (17.6)a | 100.9 (16.6)a | 108.1 (13.2)a | 100 (15) |
| SDQ (SD) | 15.1 (7) | 11 (6.7)b | 5.3 (4.7)b | 8.44 (5.8) |
| SDQ (range) | 3–29 | 1–29 | 0–14 | – |
| ASSQ (SD) | 16.1 (11) | 7.8 (8.6) | 2.9 (3.8) | 3.29 (4.5) |
| ASSQ (range) | 0–40 | 0–39 | 0–15 | |
| SNAP‐IV | 1 (0.7) | 0.5 (0.6) | 0.3 (0.3) | 0.75 (0.75) |
| SNAP‐IV (range) | 0–2.4 | 0–2.6 | 0–1.1 | – |
aStatistically significant difference at the p<0.050 level. bStatistically significant difference at the p<0.050 level on the multivariate analysis of variance with Full‐scale IQ (FSIQ) and age as covariates. CSE, convulsive status epilepticus; NA, not applicable.